Medicago lowers warrant exercise price

The Toronto Stock Exchange has conditionally approved a reduction of the exercise price of Medicago (TSX:MDG) warrants issued in November, 2009 to 43 cents from $1. The warrants expire on Nov. 26, 2010. There are 8,050,000 outstanding, including 53,888 warrants held by Medicago insiders, which will remain at the original exercise price of $1. Proceeds [...]

Medicago in funding talks for U.S. vaccine plant

Medicago (TSX:MDG) has begun negotiating final terms and conditions with the U.S. Defense Advanced Research Projects Agency (DARPA) for a financing package to build a scalable plant to make plant-expressed, virus-like particles (VLP) vaccines. Medicago submitted its proposal for the plant in March, 2010.  ”Our proposal being selected by DARPA for potential funding demonstrates our [...]